Next, cardiomyocyte surface area, atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and GATA4 expressions were ascertained to validate the incidence of cardiac hypertrophy (Figures 2C–H). The gene discussed is NPPA; the disease is cardiac hypertrophy.